Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.

Zhang D, Yu M, Xu T, Xiong B.

Hepatogastroenterology. 2013 Sep;60(126):1297-301. doi: 10.5754/hge121125.

PMID:
23933921
2.

Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.

Yang XQ, Li Y, Chen C, Peng CW, Liu SP, Liu Y.

Med Oncol. 2011 Sep;28(3):789-95. doi: 10.1007/s12032-010-9518-z. Epub 2010 Apr 7.

PMID:
20373053
3.

Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.

Sasaki A, Kawano K, Inomata M, Shibata K, Matsumoto T, Kitano S.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1814-9.

PMID:
16334783
4.

Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.

Hatate K, Yamashita K, Hirai K, Kumamoto H, Sato T, Ozawa H, Nakamura T, Onozato W, Kokuba Y, Ihara A, Watanabe M.

Oncol Rep. 2008 Oct;20(4):737-43.

PMID:
18813812
5.

A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.

Kumar Y, Pinedo IR, Tapuria N, Zabron A, Davidson BR.

Eur J Gastroenterol Hepatol. 2008 Oct;20(10):1006-11. doi: 10.1097/MEG.0b013e3282f857a7.

PMID:
18787469
6.

[Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].

Grotowski M, Maruszyński M, Piechota W.

Pol Merkur Lekarski. 2001 Dec;11(66):476-9. Polish.

PMID:
11899841
7.

[Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].

Porembska Z, Skwarek A, Chrzanowska A, Mielczarek M, Nyckowski P, Barańczyk-Kuźma A.

Pol Merkur Lekarski. 2004 Jan;16(91):31-3. Polish.

PMID:
15074017
8.

Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.

Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J.

Dis Markers. 2000;16(3-4):105-10.

9.

Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.

Jiexian J, Xiaoqin X, Lili D, Baoguo T, Ting S, Xianwen Z, Cunzhi H.

Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023.

PMID:
23787496
10.

Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.

Lin PC, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS, Chang SC.

Int J Colorectal Dis. 2012 Oct;27(10):1333-8. Epub 2012 Mar 20.

PMID:
22426691
11.

Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.

Lai IR, Lee WJ, Huang MT, Lin HH.

Hepatogastroenterology. 2002 Jul-Aug;49(46):1157-60.

PMID:
12143226
12.

CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.

Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM.

Hepatogastroenterology. 2002 Jan-Feb;49(43):160-4.

PMID:
11941943
13.

The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.

Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, Vannini P.

J Cancer Res Clin Oncol. 1998;124(8):450-5.

PMID:
9750022
14.

CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.

Yang AP, Liu J, Lei HY, Zhang QW, Zhao L, Yang GH.

Clin Chim Acta. 2014 Nov 1;437:183-6. doi: 10.1016/j.cca.2014.07.034. Epub 2014 Jul 30.

PMID:
25086284
15.

Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.

Qi J, Qian C, Shi W, Wu X, Jing R, Zhang L, Wang Z, Ju S.

Clin Biochem. 2013 Jan;46(1-2):64-9. doi: 10.1016/j.clinbiochem.2012.08.026. Epub 2012 Sep 10.

PMID:
22975639
16.

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.

He CZ, Zhang KH, Li Q, Liu XH, Hong Y, Lv NH.

BMC Gastroenterol. 2013 May 14;13:87. doi: 10.1186/1471-230X-13-87.

17.

The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.

Wang YR, Yan JX, Wang LN.

J Cancer Res Ther. 2014 Dec;10 Suppl:307-9. doi: 10.4103/0973-1482.151538.

18.

Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.

Sakamoto Y, Miyamoto Y, Beppu T, Nitta H, Imai K, Hayashi H, Baba Y, Yoshida N, Chikamoto A, Baba H.

Anticancer Res. 2015 Apr;35(4):2359-68.

PMID:
25862901
19.
20.

Supplemental Content

Support Center